PharmaTimes -
May 2022

Late expectations

It’s fair to say that certain aspects of our industry have taken a while to change – in some cases several centuries! Notably among these are public image, internal demographics, understanding the totality of ‘end users’ and, more recently, cyber adaptation.

Perhaps all these roads lead to the all-encompassing digital zeitgeist, which pharma has gradually and, in the past few years, rapidly seized. Indeed, through modern connectivity the ultra-modern ‘patient 2.0’ has risen, the gravitas of gender parity has been profoundly highlighted and the majesty of difference has become undeniable.

Caricatures are difficult to alter but our industry is making progress and, as a result, its bedrock of life sciences advancement is also finding new gears. To paraphrase; ‘very little can happen in the fields of equality, diversity, inclusion and patient engagement for centuries and then decades can unfold in a couple of years’.

Getting closer to the very people we serve, and breaking bread with them as equals, while also making them stakeholders in the development of therapies is, in many ways, the promised land. It engenders trust, provides the touchpaper for transparency, reboots clinical trial design and, mercifully, encourages cross-sector collaborations with the NHS.

This recalibrating of the pharmaverse, and everyone’s place in it, is truly fascinating and many of the features in this month’s PharmaTimes orbit around it.

From a purely selfish point of view, these complex relationships also make my job much more interesting.

Enjoy the magazine.

May 2022 - magazine highlights

Thumbnail image for The rise of patient 2.0

The rise of patient 2.0

Janssen’s Emily Bone talks about modern patient engagement evolution and why it is the driving force for a brave new era

Thumbnail image for Space invaders

Space invaders

Next-generation cell and gene therapies are spurring demand for manufacturing space in key life sciences clusters

Thumbnail image for Awakenings

Awakenings

Conscious digital transformation across healthcare and the NHS is gradually happening but significant challenges are afoot

Thumbnail image for New balance

New balance

Levelling up on prescribing, acting on variations in prescribing practice and solving health inequalities have provided the NHS with an era-specific agenda

Thumbnail image for Seizing the zeitgeist

Seizing the zeitgeist

Hannah Riley talks about women’s health, the contraception gap and the importance of owning the narrative

Thumbnail image for  The incredible journey

The incredible journey

Hayley Scutts reflects on an inspiring and intrepid route to a nursing career – which started as a patient

Thumbnail image for Data with destiny

Data with destiny

How we recognise and respond to disease is evolving – our future is inseparable from it

Thumbnail image for That’s democracy

That’s democracy

Democratising clinical trials among patient groups must become a pivotal target throughout the healthcare ecosystem

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download